4 Results for "

extensive-stage small cell lung cancer

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "extensive-stage small cell lung cancer" in MCE Product Catalog:

Cat. No.: HY-P99422
CAS No.: 2247114-85-6
Synonyms: SHR-1316

Target:  

PD-1/PD-L1 Apoptosis

Research Areas:  

Cancer

Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. Adebrelimab has promising antitumor activity in solid tumors including extensive-stage small-cell lung cancer (SCLC) .
loading...
    loading...
Cat. No.: HY-160715
CAS No.: 2296821-50-4
Research Areas:  

Cancer

BNT411 is a selective TLR7 agonist that can induce the release of IFNa both in vivo and in vitro. BNT411 has anticancer activity and can be used in cancer research, including non-small cell lung cancer, pancreatic cancer, and untreated extensive-stage small cell lung cancer (ES-SCLC) .
loading...
    loading...
Cat. No.: HY-185279
CAS No.: 3042849-33-9
Synonyms: HS-20093; GSK5764227
Research Areas:  

Cancer

Risvutatug rezetecan (HS-20093; GSK5764227) is a B7-H3-targeting antibody-drug conjugate (ADC). Risvutatug rezetecan binds to B7-H3 on tumor cells and delivers a topoisomerase I inhibitor payload via a tumor microenvironment-responsive cleavable linker. Risvutatug rezetecan is applicable for the research of extensive-stage small cell lung cancer and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-188059
CAS No.: 3058592-88-1
Synonyms: ZL-1310
Zocilurtatug pelitecan (ZL-1310) is a blood-brain barrier-penetrating antibody-drug conjugate targeting DLL3. It consists of the antibody component Zocilurtatug (HY-P992148) and the toxin-linker molecule DL-01 (HY-155870). Zocilurtatug pelitecan induces cell cycle arrest and apoptosis in tumor cells, and inhibits the growth of established human tumors in xenograft models. It can be used in research on extensive-stage small cell lung cancer (SCLC) and neuroendocrine tumors .
loading...
    loading...